Your session is about to expire
← Back to Search
ED-LINC for Opioid Use Disorder (ED-LINC2 Trial)
ED-LINC2 Trial Summary
This trial is testing a new way of delivering healthcare targeting behavioral health or substance abuse that has shown promise in earlier studies. The team is testing whether this new way (ED-LINC) is more effective than usual care in reducing self-reported illicit opioid use, increasing use of medications for opioid abuse disorder, and reducing emergency department utilization.
ED-LINC2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowED-LINC2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ED-LINC2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can provide a phone number and another way to contact me.I do not speak English.I am 18 years old or older.I am in the hospital for a mental health crisis needing urgent psychiatric evaluation.I am receiving comfort care for a chronic illness like advanced cancer.I have been taking prescribed opioids regularly for the last 3 months for chronic pain.I have a phone or another way to be contacted.
- Group 1: Usual Care
- Group 2: ED-LINC Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What objectives have been set for completion of this trial?
"This trial's primary purpose, which will be assessed at baseline and 1, 3, 6, and 12 months post-ED visit is to initiate medications for OUD. Subordinate aims include evaluating the effects of methamphetamine use (as measured by timeline follow-back) on the intervention’s outcomes; exploring how anxiety impacts outcome results; as well as tracking engagement in MOUD - including buprenorphine, methadone & naltexone – over a year after index ED visitation through state data regarding prescriptions/medication administrations combined with patient self-reporting."
Does this trial currently have openings for participants?
"Yes, the latest information from clinicaltrials.gov suggests that this medical trial is recruiting participants - it was initially posted on April 12th 2022 and amended as recently as May 13th 2022. It requires 500 individuals to be sourced from a single site."
How many participants are currently involved in this experiment?
"Affirmative. According to clinicaltrials.gov, this trial is recruiting now, with the initial posting of April 12th 2022 and last update on May 13th 2022. The study will involve 500 subjects at one medical centre."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger